ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION AS ADOPTIVE IMMUNOTHERAPY: Induction of Graft-Versus-Malignancy as Primary Therapy
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 13 (5), 1041-1057
- https://doi.org/10.1016/s0889-8588(05)70108-8
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemiaBone Marrow Transplantation, 1998
- Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donorsBone Marrow Transplantation, 1998
- Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effectBone Marrow Transplantation, 1997
- Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantationBone Marrow Transplantation, 1997
- Graft-versus-myeloma effect in two casesThe Lancet, 1996
- Clinical Significance ofbcr-ablGene Rearrangement Detected by the Polymerase Chain Reaction After Allogeneic Bone Marrow Transplantation in Chronic Myelogenous LeukemiaLeukemia & Lymphoma, 1993
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASETransplantation, 1987
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979